Filing Details
- Accession Number:
- 0001225208-22-008106
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-14 19:53:14
- Reporting Period:
- 2022-06-14
- Accepted Time:
- 2022-06-14 19:53:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204551 | A Michael Mussallem | One Edwards Way Irvine CA 92614 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-14 | 29,375 | $35.20 | 186,728 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-06-14 | 3,054 | $87.92 | 183,674 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-06-14 | 6,714 | $86.24 | 176,960 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-06-14 | 9,500 | $0.00 | 167,460 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2022-06-14 | 10,107 | $87.14 | 157,353 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-06-14 | 9,500 | $0.00 | 3,416,017 | No | 4 | G | Indirect | By Living Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Indirect | By Living Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2022-06-14 | 29,375 | $0.00 | 29,375 | $35.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 323,125 | 2016-06-12 | 2023-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 371,709 | Indirect | 401(k) |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.
- This transaction was executed in multiple trades at prices ranging from $87.645 to $88.510. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $85.630 to $86.630. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $86.640 to $87.610. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.
Billionaire Hedge Funds
